| Methods | Prospective cohort study |
| Participants | 35 patients with epilepsy and depression |
| Interventions | Fluvoxamine 50 to 200 mg (mean 125 mg) |
| Outcomes | Seizure frequency |
| Notes | No available contact details for study authors |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.